We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,511
Reduced
5,994
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRAW icon
14626
CALL
Traws Pharma
TRAW
$8.43M
-1,264
Closed -$81K
TRAW icon
14627
Traws Pharma
TRAW
$8.43M
-1,625
Closed -$104K
GRDX
14628
GridAI Technologies Corp
GRDX
$19.3M
-1
Closed -$20K
EQIN
14629
Columbia U.S. Equity Income ETF
EQIN
$312M
-8,374
Closed -$320K
FSCS
14630
First Trust SMID Capital Strength ETF
FSCS
$59.4M
-19,081
Closed -$580K
QCLS
14631
PUT
Q/C Technologies Inc
QCLS
$23M
-4
Closed -$68K
CSCI
14632
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
-1,913
Closed -$68.8K
CSCI
14633
PUT
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
-197
Closed -$7K
BGM
14634
BGM Group Ltd
BGM
$121M
-3,183
Closed -$42K
INVX
14635
PUT
Innovex International
INVX
$2.21B
-14,100
Closed -$277K
HURA
14636
TuHURA Biosciences
HURA
$133M
-142
Closed -$127K
IVF
14637
CALL
INVO Fertility Inc
IVF
$1.88M
0
-$40K
IRD
14638
PUT
Opus Genetics
IRD
$306M
-29,800
Closed -$111K
IMG
14639
CALL
DELISTED
CIMG Inc
IMG
-16
Closed -$46K
IMG
14640
DELISTED
CIMG Inc
IMG
-18
Closed -$52K
ENFY
14641
DELISTED
Enlightify Inc
ENFY
-11,990
Closed -$114K
MTVA
14642
MetaVia Inc
MTVA
$7.54M
-16
Closed -$41.7K
MTVA
14643
PUT
MetaVia Inc
MTVA
$7.54M
-20
Closed -$66K
ABXB
14644
Abacus Flexible Bond Leaders ETF
ABXB
$1.92M
-20,736
Closed -$511K
NPKI
14645
PUT
NPK International
NPKI
$1.16B
-37,700
Closed -$111K
IPM
14646
Intelligent Protection Management Corp
IPM
$23.7M
-35,819
Closed -$102K
DVLT
14647
CALL
Datavault AI
DVLT
$318M
-1
Closed -$15K
FNGA
14648
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
-11,840
Closed -$4.44M
KLRS
14649
CALL
Kalaris Therapeutics
KLRS
$103M
-513
Closed -$153K
AMZE
14650
Amaze Holdings
AMZE
$1.34M
-90
Closed -$84K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,511 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.